by
Julie Wu, MD
Seminar date: 11/8/2022
Description: The goal of precision oncology is to personalize cancer therapy, including efficient preventive cancer screening of high-risk Veterans, use of targeted cancer therapies, and improving Veteran access to clinical trials. This “works-in-progress” Cyberseminar will cover preliminary data and aims for Dr. Wu’s recently funded Merit Supplement to implement risk-stratified second primary lung cancer screening for Veterans and other ongoing VA projects in precision oncology.
Intended Audience:
CDA awardees and alumni, potential collaborators, HRSD researchers
DOWNLOAD: PDF handout | Audio only (mp3) | transcript